NFKB1 and COVID-19: Patients with severe COVID-19 exhibit less pronounced increases in TLR4 expression on CD14 monocytes than those with mild COVID-19, which is related to activation of TLR4/NF-κB axis after lipopolysaccharide stimulation (75).